MarketWatch
Jaimy Lee
원문 기사 18건
MarketWatch · 2026. 11. 16.
The FDA declined to approve one of biotech’s most closely watched cancer drugs. The company’s stock tumbled.MarketWatch · 2026. 11. 9.
A failed trial for a heart drug casts shadow over rivals developing similar therapiesMarketWatch · 2026. 10. 23.
The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.MarketWatch · 2026. 10. 22.
Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbledMarketWatch · 2026. 10. 19.
Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.MarketWatch · 2026. 10. 15.
Big pharma stocks close near all-time highs as tech selloff pushes investors toward safer betsMarketWatch · 2026. 10. 13.
UnitedHealth keeps medical costs under control — and raises its outlook againMarketWatch · 2026. 9. 23.
This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approvalMarketWatch · 2026. 9. 22.
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a monthMarketWatch · 2026. 9. 21.
Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategyMarketWatch · 2026. 9. 10.
Why $500 checks won’t help Americans facing 15% increases in Obamacare premiums next yearMarketWatch · 2026. 9. 3.
Oura files for IPO amid Americans’ obsession with tracking their sleep, steps and heart ratesMarketWatch · 2026. 8. 20.
Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhypedMarketWatch · 2026. 8. 14.
Luigi Mangione pleads guilty in federal court to stalking health-insurance CEOMarketWatch · 2026. 7. 28.
Medicare is about to change a drug program that held down the cost of premiums. Here’s what to know.MarketWatch · 2026. 7. 24.
FDA advisers say six popular peptides can be compounded. Here are the issues they considered.MarketWatch · 2026. 7. 23.
Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.MarketWatch · 2026. 7. 20.
Americans are skipping lettuce and salads as investigation into cyclospora outbreak continues